1199-04-8Relevant academic research and scientific papers
COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
-
Page/Page column 19-20, (2009/01/23)
The invention provides a novel class of compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or dysregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1, 4, 5- trisphosphate 3 -kinase B (ITPKb).
